Lumexa Imaging Holdings, Inc. - Common Stock (LMRI)

Record advanced imaging mix sits alongside a sharp drop in net leverage.

Lumexa Imaging (NASDAQ:LMRI) reported higher third-quarter revenue and a return to profitability as growth in advanced imaging procedures helped lift results across its outpatient network and health system joint ventures. The company narrowed its full-year adjusted EBITDA guidance and raised its ad

RALEIGH, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the third quarter ended September 30, 2026.

RALEIGH, N.C., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its third quarter 2026 financial and operational results after market close on Tuesday, November 10, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences:

Advanced imaging volumes surge as free cash flow hits record $23.1 million.

Lumexa Imaging (NASDAQ:LMRI) reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance. Chief Executive Officer Caitlin Zulla said the

RALEIGH, N.C., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated its full year 2026 outlook. 

RALEIGH, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its second quarter 2026 financial and operational results after market close on Wednesday, August 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

This collaboration marks Lumexa Imaging’s ninth joint venture and advances the company’s health system growth strategy

Lumexa Imaging (LMRI) Q4 2025 Earnings Transcript

Lumexa (LMRI) Q1 2026 Earnings Transcript

Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and weather-related disruptions. Chief Executive Officer Caitlin Zulla said the company “recovered our mom

RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced results for the first quarter ended March 31, 2026, and reiterated full year 2026 guidance. 

RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced it will release its first quarter 2026 financial and operational results after market close on Tuesday, May 12, 2026. The Company will host a conference call and live webcast to discuss the results at 5:00 p.m. ET.

Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging’s platform

RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today announced certain financial results for the fourth quarter ended December 31, 2025, and reiterated full year 2026 guidance. The financial results included in this release pertaining to the fourth quarter and full year 2025 are preliminary, unaudited, and subject to final review and adjustment.

New York, NY – December 11, 2025 – Lumexa Imaging Holdings (NASDAQ: LMRI), a leading provider of diagnostic imaging services, made its public market debut today, pricing its initial public offering (IPO) at $18.50 per share. The successful launch, which raised approximately $463 million, positions Lumexa as a significant new entrant